Who We Are: Our Leaders

Kunle Odunsi, MD, PHD, FRCOG, FACOG

Dr. Odunsi is Chair of the Department of Gynecologic Oncology, Executive Director of the Center for Immunotherapy and Co-Leader of the Tumor Immunology and Immunotherapy research program at Roswell Park Comprehensive Cancer Center. His research interests include the molecular characterization of tumor antigens in ovarian cancer and their application to the development of vaccine for the disease. Under the direction of Dr. Odunsi the Registry is currently conducting innovative research to learn more about the causes of familial cancer. His hope is to discover new genes that predispose a woman to the development of ovarian cancer, which will help to better detect and ultimately prevent this disease.

Shasikant Lele, MD, FACOG

Dr. Lele is Clinical Chief of Gynecologic Oncology and Clinical Chair, Division of Surgical Subspecialties at Roswell Park Comprehensive Cancer Center. His research interests include Gynecologic Oncology Group studies involving clinical and scientific research as well as ovarian cancer surgery and ovarian cancer chemotherapy. He actively recruits and counsels patients with ovarian cancer, as well as their family members. This recruitment leads to knowledge about research objectives to help them as well as others with this disease.

Our History

The registry was established in 1981 by M. Steven Piver, M.D., former chairman of the Department of Gynecologic Oncology at Roswell Park Comprehensive Cancer Center —America’s first cancer center, located in Buffalo, NY.

In May 1990, it was named The Gilda Radner Registry to honor the memory of American comedian, Gilda Radner, who died of ovarian cancer in 1989. Gene Wilder, actor and producer, was Gilda’s husband. Mr. Wilder generously agreed to lend his late wife’s name to the registry in an effort to increase awareness of the disease and to help national research efforts.

The registry was renamed the Familial Ovarian Cancer Registry in 2013 to help expand awareness worldwide, and to foster increased collaborative partnerships with hospitals and research centers across the world.